A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Clinical trial NCT06976203 · RECRUITING
Trial details
- NCT number
- NCT06976203
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-21
- Primary completion
- 2028-09-11
- Enrollment
- 586
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.